Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Tonix Pharmaceuticals Holding (TNXP) Receivables - Net (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of Receivables - Net data on record, last reported at $3.5 million in Q3 2025.

  • For Q3 2025, Receivables - Net rose 113.69% year-over-year to $3.5 million; the TTM value through Sep 2025 reached $3.5 million, up 113.69%, while the annual FY2024 figure was $3.7 million, 19.76% down from the prior year.
  • Receivables - Net reached $3.5 million in Q3 2025 per TNXP's latest filing, up from $2.3 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $4.6 million in Q4 2023 and bottomed at $1.6 million in Q3 2023.
  • Average Receivables - Net over 3 years is $3.0 million, with a median of $3.3 million recorded in 2024.
  • The widest YoY moves for Receivables - Net: up 113.69% in 2025, down 30.52% in 2025.
  • A 3-year view of Receivables - Net shows it stood at $4.6 million in 2023, then dropped by 19.76% to $3.7 million in 2024, then fell by 5.48% to $3.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables - Net were $3.5 million in Q3 2025, $2.3 million in Q2 2025, and $3.3 million in Q1 2025.